---
figid: PMC7478739__JEM_20192389_Fig6
figtitle: SOAT1 abrogates cholesterol feedback inhibition to promote mevalonate pathway
  dependency in PDAC
organisms:
- NA
pmcid: PMC7478739
filename: JEM_20192389_Fig6.jpg
figlink: pmc/articles/PMC7478739/figure/fig6/
number: F6
caption: SOAT1 abrogates cholesterol feedback inhibition to promote mevalonate pathway
  dependency in PDAC. Model illustrating the role of SOAT1 in sustaining the activity
  of the mevalonate pathway. (A and B) Typically, compared with normal and preneoplastic
  pancreatic cells (A), SOAT1 levels, SREBP2 activity, and the expression of mevalonate
  pathway genes are up-regulated in PDAC cells with mutant p53 and LOH of WT p53 (B).
  (C and D) SOAT1 abrogation and consequential mevalonate pathway inhibition do not
  affect the proliferation of normal and preneoplastic pancreatic cells (C), whereas
  they significantly impair the proliferation of PDAC cells with mutant p53 that have
  undergone p53 LOH (D). SREBP2-p, inactive SREBP2 precursor. SREBP2-m, mature SREBP2
  protein.
papertitle: SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.
reftext: Tobiloba E. Oni, et al. J Exp Med. 2020 Sep 7;217(9):e20192389.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9141807
figid_alias: PMC7478739__F6
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7478739__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7478739__JEM_20192389_Fig6.html
  '@type': Dataset
  description: SOAT1 abrogates cholesterol feedback inhibition to promote mevalonate
    pathway dependency in PDAC. Model illustrating the role of SOAT1 in sustaining
    the activity of the mevalonate pathway. (A and B) Typically, compared with normal
    and preneoplastic pancreatic cells (A), SOAT1 levels, SREBP2 activity, and the
    expression of mevalonate pathway genes are up-regulated in PDAC cells with mutant
    p53 and LOH of WT p53 (B). (C and D) SOAT1 abrogation and consequential mevalonate
    pathway inhibition do not affect the proliferation of normal and preneoplastic
    pancreatic cells (C), whereas they significantly impair the proliferation of PDAC
    cells with mutant p53 that have undergone p53 LOH (D). SREBP2-p, inactive SREBP2
    precursor. SREBP2-m, mature SREBP2 protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - modSP
  - LRP1
  - LpR2
  - mgl
  - ras
  - Ras64B
  - Ras85D
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Hmgcr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - loh
  - p53
  - betaTub60D
  - hth
  - LDLR
  - KRAS
  - HRAS
  - NRAS
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - SOAT1
  - SREBF2
  - LIMA1
  - HMGCR
  - TP53
  - TP63
  - TP73
  - Cholesterol
  - Isoprenoids
  - Mevalonate
  - ester
---
